Literature DB >> 18617781

Predictive factors of years of potential life lost by colorectal cancer.

Julian Perez-Palma1, Joaquin Marchena-Gomez, Mercedes Dorta-Espineira, Nieves Lorenzo-Rocha, Alberto Bravo-Gutierrez, Vicente Medina-Arana.   

Abstract

OBJECTIVE: To evaluate the impact of colorectal cancer (CRC) by estimating the years of potential life lost (YPLL) by this neoplasm in a cohort of patients, as well as to define the predictive factors of YPLL.
METHODS: A descriptive cross-sectional study of 980 consecutive patients diagnosed and treated because of CRC in our institution between 1985 and 2002 was carried out. Demographic, clinical, pathological, surgical, hospital stay, complications, and mortality variables were recorded. The primary endpoint of this study was to calculate individual YPLL. Univariate analysis was performed to compare each independent variable with the variable YPLL. All clinically relevant variables significantly associated with YPLL were included in an ordinal regression model to identify independent factors prognostic of YPLL.
RESULTS: The final study sample was 794 patients, 413 (52%) men and 381 (48%) women, mean age 65.3 years [confidence interval (CI) 95%: 64.4-66.2 years; SD: 12.8]. The mean global YPLL for the 351 patients who died of CRC was 15.2 years (SD: 10.7; CI 95%: 14.1-16.3). Lower age [odds ratio (OR)=0.98; CI 95%: 0.97-0.98], male sex (OR=1.19; CI 95%: 1.00-1.43), lower tumor, nodes, metastasis (TNM) stage (OR=0.29; CI 95%: 0.24-0.35), and rectum localization of the tumor (OR=1.37; CI 95%: 1.14-1.64) were independent prognostic factors for YPLL.
CONCLUSION: In our community, the mean number of YPLL by CRC exceeds 15 years. Lower age, male sex, higher TNM stage, and rectum localization are negative predictors of YPLL.

Entities:  

Mesh:

Year:  2008        PMID: 18617781     DOI: 10.1097/MEG.0b013e3282fbf5d3

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  2 in total

1.  Evaluation of CD44 and CD44v6 in colorectal carcinoma patients: soluble forms in relation to tumor tissue expression and metastasis.

Authors:  Zahra Amirghofran; Seyed Amir Jalali; Seyed Vahid Hosseini; Mohammad Vasei; Behnam Sabayan; Abbas Ghaderi
Journal:  J Gastrointest Cancer       Date:  2009-03-31

2.  Assessing how health information needs of individuals with colorectal cancer are met across the care continuum: an international cross-sectional survey.

Authors:  Hallie Dau; Abdollah Safari; Khalid Saad El Din; Helen McTaggart-Cowan; Jonathan M Loree; Sharlene Gill; Mary A De Vera
Journal:  BMC Cancer       Date:  2020-10-27       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.